XML 124 R77.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Financial Information of Parent Company - Schedule of Parent-only Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Assets        
Total assets $ 1,470,114 $ 386,796    
Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)        
Total liabilities 758,755 737,369    
Redeemable convertible preferred stock        
Redeemable convertible preferred stock, $0.006 par value; zero and 130,000 shares authorized at December 31, 2020 and December 31, 2019, respectively; and zero and 126,046 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively   737,009    
Stockholders' equity (deficit)        
Additional paid-in capital 2,101,773 8,788    
Accumulated deficit (1,390,453) (1,096,830)    
Total stockholders' equity (deficit) 711,359 (1,087,582) $ (1,162,427) $ (31,753)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) 1,470,114 386,796    
Common Stock        
Stockholders' equity (deficit)        
Common stock   460    
Total stockholders' equity (deficit)   460 $ 451 $ 157
Class A and Class B Common Stock        
Stockholders' equity (deficit)        
Common stock 39      
Total stockholders' equity (deficit) 39      
GoodRx Holdings, Inc        
Assets        
Cash 5 110    
Other asset 57 147    
Investment in subsidiary, net of distributions 711,384      
Total assets 711,446 257    
Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)        
Investment in subsidiary, net of distributions   350,830    
Other current liabilities 87      
Total liabilities 87 350,830    
Redeemable convertible preferred stock        
Redeemable convertible preferred stock, $0.006 par value; zero and 130,000 shares authorized at December 31, 2020 and December 31, 2019, respectively; and zero and 126,046 shares issued and outstanding at December 31, 2020 and December 31, 2019, respectively   737,009    
Stockholders' equity (deficit)        
Additional paid-in capital 2,101,773 8,788    
Accumulated deficit (1,390,453) (1,096,830)    
Total stockholders' equity (deficit) 711,359 (1,087,582)    
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit) 711,446 257    
GoodRx Holdings, Inc | Common Stock        
Stockholders' equity (deficit)        
Common stock   $ 460    
GoodRx Holdings, Inc | Class A and Class B Common Stock        
Stockholders' equity (deficit)        
Common stock $ 39